| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ML320 | CTRPv2 | pan-cancer | AAC | 0.0085 | 0.8 |
| mRNA | JQ-1 | CTRPv2 | pan-cancer | AAC | -0.0073 | 0.8 |
| mRNA | quizartinib | CTRPv2 | pan-cancer | AAC | -0.0086 | 0.8 |
| mRNA | CIL55A | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | LE-135 | CTRPv2 | pan-cancer | AAC | 0.0084 | 0.8 |
| mRNA | Obatoclax Mesylate | CTRPv2 | pan-cancer | AAC | 0.0076 | 0.8 |
| mRNA | MLN4924 | CTRPv2 | pan-cancer | AAC | 0.0076 | 0.8 |
| mRNA | chlorambucil | CTRPv2 | pan-cancer | AAC | -0.0069 | 0.8 |
| mRNA | BRD-K99006945 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | fingolimod | CTRPv2 | pan-cancer | AAC | -0.0077 | 0.8 |